LOGN:SIXLogitech International S.A. Analysis
Data as of 2026-03-13 - not real-time
$32.35
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Logansport Financial (LOGN) is trading at $32.35, comfortably above its 20‑day ($32.08), 50‑day ($32.01) and 200‑day ($31.19) simple moving averages, signaling a strong bullish bias. The MACD histogram is positive and the signal line is bullish, while the RSI sits at 61, indicating momentum is still healthy but not yet overbought. Price is perched near the calculated resistance of $32.46 with a solid support base at $31.61, and the recent volume trend is decreasing, suggesting a quieter market environment. A near‑zero beta (‑0.01) and a 30‑day volatility of about 11% point to low systematic risk and moderate price swings. Valuation metrics are attractive: a trailing P/E of 11.3 versus an industry average of 16.4, a price‑to‑book of 0.87, and a dividend yield of 5.56% backed by a 62% payout ratio, all of which imply the stock is undervalued and offers a generous income stream. Operating performance is solid with 9% revenue growth, a 22% operating margin and a 19% profit margin, delivering an ROE of roughly 8%.
However, liquidity is a concern – the market cap is only $19.8 M, average daily volume is under 300 shares and the float appears thin, raising the liquidity risk. The regional‑bank sector carries medium regulatory and credit risk, and the stock’s max drawdown of 14% over the past period highlights downside potential. Despite a cash balance of $7.5 M, total debt sits at $15 M, so balance‑sheet leverage warrants monitoring, but earnings remain positive, supporting the current dividend.
However, liquidity is a concern – the market cap is only $19.8 M, average daily volume is under 300 shares and the float appears thin, raising the liquidity risk. The regional‑bank sector carries medium regulatory and credit risk, and the stock’s max drawdown of 14% over the past period highlights downside potential. Despite a cash balance of $7.5 M, total debt sits at $15 M, so balance‑sheet leverage warrants monitoring, but earnings remain positive, supporting the current dividend.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with bullish technical alignment
- High dividend yield provides cushion
- Decreasing volume and liquidity risk limit upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued valuation relative to peers
- Stable earnings growth and solid profit margins
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low systematic risk (beta near zero) and modest volatility
- Consistent profitability and dividend track record
- Undervaluation provides margin of safety despite sector headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth8.90%
Profit Margin19.19%
P/E Ratio11.3
ROE8.17%
ROA0.67%
P/B Ratio0.9
Industry P/E16.4
Technical Analysis
TrendBullish
RSI61.1
Support$31.61
Resistance$32.46
MA 20$32.08
MA 50$32.01
MA 200$31.19
MACDBullish
VolumeDecreasing
Fear & Greed Index72.8
Valuation
GradeUndervalued
TypeValue
Dividend Yield5.56%
Risk Assessment
Beta-0.01
Volatility11.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.